Literature DB >> 3599310

The potent pressor effect of phenylpropanolamine in patients with autonomic impairment.

I Biaggioni, J Onrot, C K Stewart, D Robertson.   

Abstract

We determined the pressor effect of phenylpropanolamine hydrochloride, a widely used sympathomimetic agent, in 14 patients with autonomic failure and orthostatic hypotension. Blood pressure was monitored every five minutes in the sitting position with an automated device. Oral administration of 25 mg of phenylpropanolamine hydrochloride in nine patients produced significant increases in systolic (32 mm Hg), diastolic (15 mm Hg), and mean (21 mm Hg) blood pressures. The pressor effect appeared within the first 60 minutes and was still present at 105 minutes. There was no change in heart rate. Blood pressure was also significantly raised by administration of 12.5 mg of oral phenylpropanolamine hydrochloride in five additional patients. We conclude that administration of 25 mg of phenylpropanolamine hydrochloride elicits a potent pressor response in patients with orthostatic hypotension and that significant hypertension may result.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3599310

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

Review 1.  New trends in the treatment of orthostatic hypotension.

Authors:  J Jordan
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Autonomic dysfunction: diagnosis guided by therapy.

Authors:  R M Robertson; I Biaggioni; R Mosqueda-Garcia; D Robertson
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 3.  Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.

Authors:  J M Senard; C Brefel-Courbon; O Rascol; J L Montastruc
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Pure Autonomic Failure.

Authors:  Elizabeth A Coon; Wolfgang Singer; Phillip A Low
Journal:  Mayo Clin Proc       Date:  2019-09-09       Impact factor: 7.616

Review 5.  Non-prescription sympathomimetic agents and hypertension.

Authors:  S S Chua; S I Benrimoj
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

6.  Renal impairment of pure autonomic failure.

Authors:  Emily M Garland; Alfredo Gamboa; Luis Okamoto; Satish R Raj; Bonnie K Black; Thomas L Davis; Italo Biaggioni; David Robertson
Journal:  Hypertension       Date:  2009-09-08       Impact factor: 10.190

7.  Chronic sympathetic attenuation and energy metabolism in autonomic failure.

Authors:  Cyndya Shibao; Maciej S Buchowski; Kong Y Chen; Chang Yu; Italo Biaggioni
Journal:  Hypertension       Date:  2012-04-02       Impact factor: 10.190

8.  Autonomic Blockade Reverses Endothelial Dysfunction in Obesity-Associated Hypertension.

Authors:  Alfredo Gamboa; Rocío Figueroa; Sachin Y Paranjape; Ginnie Farley; Andre Diedrich; Italo Biaggioni
Journal:  Hypertension       Date:  2016-08-15       Impact factor: 10.190

9.  The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache.

Authors:  D Robertson; D W Kincaid; V Haile; R M Robertson
Journal:  Clin Auton Res       Date:  1994-06       Impact factor: 4.435

Review 10.  Current pharmacologic treatment for orthostatic hypotension.

Authors:  Roy Freeman
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.